Patient Reported Outcomes With WaveLight Plus LASIK

Part of paid clinical trials in Houston, Texas.

Sponsor
Mann Eye Institute
Study ID
NCT07084844
Status
Recruiting
Apply to this trial

Conditions

  • Astigmatism
  • Myopia

Eligibility Criteria

Sex
ALL
Age
18 Years - 39 Years
Healthy Volunteers
Not accepted

Interventions

  • WaveLigh Plus LASIK — DEVICE
    Wavelight plus LASIK is an advanced laser eye surgery technology designed to enhance visual outcomes through personalized treatment plans. This system integrates comprehensive diagnostics, including biometry, tomography, and wavefront measurements, to create a tailored ablation profile for each patient.

Study Details

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.

Key Dates

Start date
Sep 5, 2025
Status verified
Sep 2025
Primary completion
Sep 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
52 participants (estimated)

Primary Outcome Measure

Mean score of satisfaction with uncorrected vision after wavelight plus LASIK based on PROWL-SS Questionnaire preoperative vs postoperative (question #1 [Q1] only). [ Time Frame: 3 months postoperative ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mann Eye InstituteHoustonTexas77004
Study Coordinator
[email protected]
713-580-2500
Phillip Brunson (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
Mann Eye Institute· Houston, TX

Related Studies